Click Therapeutics News and Activities

Acquisition, funding and merger involving Click Therapeutics.

• Click Therapeutics has just announced a $50 Million fundraising (posted on April 12 2026).

View the org chart displaying its 19 main executives

Most searched biographies at Click Therapeutics

• David Klein, Chief Executive Officer and Director
• Cris De Luca, Board Member
• David Friedman, Director

Create your alert
to follow the executive moves at Click Therapeutics.

Click Therapeutics has 2,406 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Click Therapeutics

• Click Therapeutics and Boehringer Ingelheim Announce Series D Investment and Funding to Advance Commercialization of CT-155
• Ultrahuman and Click Therapeutics partner to launch the world’s first biomarker-driven migraine management tool based on FDA-authorized technology
• Boehringer and Click Therapeutics present pivotal data for investigational prescription digital therapeutic CT-155 showing a statistically significant reduction in negative symptoms of schizophrenia
• Click Therapeutics Insights
• Boehringer and Click Therapeutics’ investigational prescription digital therapeutic CT-155 meets primary endpoint in CONVOKE study for negative symptoms in schizophrenia
• Click Therapeutics Announces FDA Marketing Authorization for CT-132, the First Prescription Digital Therapeutic for the Preventive Treatment of Episodic Migraine in the United States
• Click Therapeutics Underscores Its Commitment to Innovation and Leadership in Software as Prescription Medical Treatments with Launch of New Brand Identity
• Click Therapeutics Insights
• Click Therapeutics Announces Series C, Dassault Systèmes and Medidata Make Strategic Investment
• Click Therapeutics Launches Software-Enhanced Drug™ Therapies as part of new Click SE™ Offering | Click Therapeutics
• View more press releases Close

Social media about Click Therapeutics

• Click Therapeutics on Wikipedia, Google News & Yahoo Finance
• Click Therapeutics on LinkedIn, X (Twitter) & YouTube